We now know which submissions will be considered at the March 2025 PBAC meeting but not which will not. The committee will consider submissions for five biosimilars.
We now know what will be considered in March, but not what has been pushed to May
November 29, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective,
December 6, 2024 - - Latest News -
Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing
December 6, 2024 - - BioPharma -
Former CSL CEO Paul Perreault appointed strategic adviser to Microbio
December 5, 2024 - - Latest News -
More evidence backs the use of weight-loss therapies
December 5, 2024 - - Latest News -
ChatGPT would have produced more human responses than these committees
December 5, 2024 - - Latest News -
Anatara provides irritable bowel syndrome clinical trial update
December 4, 2024 - - Australian Biotech -
Digital health company Adherium secures R&D loan facility
December 4, 2024 - - Australian Biotech